Tishman Speyer, Bellco Capital Provide $90M Refi for San Diego Life Sciences Campus

Why this matters

This refinancing transaction underscores the sustained institutional appetite for life sciences real estate, particularly in established innovation hubs like San Diego. The deployment of mezzanine debt to refinance a large, newly opened Class A campus signals confidence in the sector’s cash flow resilience and long-term growth prospects, despite broader macroeconomic uncertainties. Mezzanine financing, positioned between senior debt and equity, often reflects lenders’ willingness to accept incremental risk for enhanced returns, suggesting that capital providers remain constructive on life sciences fundamentals and tenant demand. For allocators and capital markets professionals, this deal highlights the ongoing prioritization of specialized assets that benefit from secular drivers such as biotech innovation and R&D expansion. It also illustrates how capital stacks are evolving, with mezzanine layers becoming a preferred tool to optimize leverage while managing senior debt exposure amid tighter lending conditions. The transaction may further indicate that sponsors are actively managing capital structures to preserve liquidity and flexibility in a competitive market. Overall, this refinancing reinforces life sciences real estate’s role as a core sector within US institutional portfolios, supported by durable demand and adaptive financing strategies.

Editorial analysis · AI-assisted

On the RET wire

• The 19th San Diego story tracked on the wire in July 2026. All San Diego coverage →
• Disclosed capital deal value tracked in July 2026: $22.3B across 56 reported transactions.
• 25 stories mentioning Tishman on the wire in the past 90 days. Tishman coverage →

Computed from Real Estate Trail’s own tracked coverage

External link. Real Estate Trail does not republish source content.